Structure Therapeutics Balance Sheet
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Structure Therapeutics financial position
At the end of fiscal 2025, Structure Therapeutics reported total assets of $1.58 billion, up 75.3% from a year earlier against total liabilities of $67.5 million. Shareholders' equity stood at $1.52 billion, or 95.7% of assets. The company held $799.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 24.81, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Structure Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 |
|---|---|---|---|---|
| Cash & Equivalents | 799.62M | 169.51M | 129.79M | 26.09M |
| Short-Term Investments | 646.57M | 714.01M | 337.53M | 64.75M |
| Total Current Assets | 1.57B | 891.21M | 473.61M | 93.09M |
| Property, Plant & Equipment | 6.65M | 3.48M | 3.23M | 1.03M |
| Total Assets | 1.58B | 903.33M | 482.02M | 97.84M |
| Accounts Payable | 13.86M | 8.02M | 4.74M | 6.01M |
| Total Current Liabilities | 63.28M | 36.02M | 24.74M | 13.01M |
| Total Liabilities | 67.54M | 38.49M | 29.05M | 13.01M |
| Shareholders' Equity | 1.52B | 864.84M | 452.97M | -115.14M |
| Retained Earnings | -470.30M | -329.10M | -206.57M | -116.95M |
| Net Cash (Debt) | 1.45B | 883.52M | 467.32M | 90.84M |
| Shares Outstanding | 212.51M | 171.86M | 139.22M | 10.53M |
This table shows 4 annual periods of Structure Therapeutics's balance sheet, from FY 2025 back to FY 2022, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow GPCR's reporting calendar. What is a balance sheet?